货号:GS40139
Clesrovimab is an investigational extended-half-life human monoclonal antibody developed for the prevention of respiratory syncytial virus (RSV) infection in vulnerable populations. Engineered with modified Fc regions, it is designed to provide prolonged protection against RSV, reducing the frequency of dosing compared to earlier prophylactic antibodies. Its primary development focus is to protect high-risk infants and young children during the RSV season.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物